key: cord-0927537-mxje0o0b
authors: Mancini, Donna M.; Natelson, Benjamin H.
title: Reply: CPET for Long COVID-19
date: 2022-02-28
journal: JACC Heart Fail
DOI: 10.1016/j.jchf.2022.01.009
sha: 4e1d4246a63a9cdb33aa39665033be7fc9f622c9
doc_id: 927537
cord_uid: mxje0o0b

nan

comorbidities (which were noted in 31 of the reported patients). Comparing with matched controls rather than predicted values would have been preferable.

Yet the patients showed erratic increases in respiratory rate, with early CPET tachypnea as typically seen in PTS. There also was a tendency to decreased peripheral EO 2 . This was wrongly calculated as arterio- The authors have reported that they have no relationships relevant to the contents of this paper to disclose. The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors' institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center. 

We appreciate the comments from Drs Naeije and Caravita and the citation of their work which was not available at the time our report was written. 1 

Phenotyping long COVID

Use of cardiopulmonary stress testing for patients with unexplained dyspnea postcoronavirus disease

The authors have reported that they have no relationships relevant to the contents of this paper to disclose. The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors' institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.